IL162111A0 - Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologo - Google Patents
Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologoInfo
- Publication number
- IL162111A0 IL162111A0 IL16211101A IL16211101A IL162111A0 IL 162111 A0 IL162111 A0 IL 162111A0 IL 16211101 A IL16211101 A IL 16211101A IL 16211101 A IL16211101 A IL 16211101A IL 162111 A0 IL162111 A0 IL 162111A0
- Authority
- IL
- Israel
- Prior art keywords
- heterologo
- generation
- production
- precursor lymphocytes
- modified vertebrate
- Prior art date
Links
- 241000251539 Vertebrata <Metazoa> Species 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2001/015303 WO2003068819A1 (en) | 2001-12-22 | 2001-12-22 | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162111A0 true IL162111A0 (en) | 2005-11-20 |
Family
ID=27675551
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16211101A IL162111A0 (en) | 2001-12-22 | 2001-12-22 | Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologo |
IL162111A IL162111A (en) | 2001-12-22 | 2004-05-20 | Method for the generation of vertebrate lymphocytes and use thereof for the production of binding proteins or functional fragment(s) thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL162111A IL162111A (en) | 2001-12-22 | 2004-05-20 | Method for the generation of vertebrate lymphocytes and use thereof for the production of binding proteins or functional fragment(s) thereof |
Country Status (8)
Country | Link |
---|---|
US (2) | US7741077B2 (xx) |
JP (1) | JP4238138B2 (xx) |
CN (1) | CN100360565C (xx) |
AU (1) | AU2002226390B2 (xx) |
CA (1) | CA2471392A1 (xx) |
IL (2) | IL162111A0 (xx) |
NZ (1) | NZ534205A (xx) |
WO (1) | WO2003068819A1 (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1568765A1 (en) * | 2004-02-23 | 2005-08-31 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Method for genetic diversification in gene conversion active cells |
WO2006072803A2 (en) * | 2005-01-10 | 2006-07-13 | Medical Research Council | Antibody |
WO2007060864A1 (ja) * | 2005-11-24 | 2007-05-31 | National University Corporation NARA Institute of Science and Technology | 増殖と分化の制御可能な抗体産生前駆b細胞 |
PT2540820T (pt) | 2005-12-09 | 2018-03-02 | Academisch Medisch Centrum Bij De Univ Van Amsterdam | Meios e métodos para influenciar a establidade de células produtoras de anticorpos |
WO2007067032A1 (en) | 2005-12-09 | 2007-06-14 | Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of cells |
US10155038B2 (en) | 2007-02-02 | 2018-12-18 | Yale University | Cells prepared by transient transfection and methods of use thereof |
US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
US8859229B2 (en) * | 2007-02-02 | 2014-10-14 | Yale University | Transient transfection with RNA |
NZ579010A (en) * | 2007-02-20 | 2012-03-30 | Anaptysbio Inc | Somatic hypermutation systems |
JP5537420B2 (ja) | 2007-05-31 | 2014-07-02 | ユニヴァーシティ オブ ワシントン | 標的遺伝子の誘導性変異誘発 |
AU2008284015B2 (en) | 2007-08-03 | 2014-05-15 | Musc Foundation For Research Development | Human monoclonal antibodies and methods for producing the same |
EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
WO2010027062A1 (ja) * | 2008-09-04 | 2010-03-11 | 独立行政法人理化学研究所 | B細胞由来iPS細胞およびその用途 |
EP2358868B1 (en) * | 2008-11-21 | 2014-11-12 | California Institute of Technology | In vitro human b lymphopoiesis culture system |
AU2010271583B2 (en) | 2009-07-15 | 2015-02-12 | Kling Biotherapeutics B.V. | Means and methods for producing high affinity antibodies |
AU2010334809C1 (en) | 2009-12-23 | 2015-02-26 | Agenus Inc. | Binding members for human cytomegalovirus |
US9074223B2 (en) * | 2010-01-08 | 2015-07-07 | Immusoft Corporation | Vectors and methods for transducing B cells |
KR101667088B1 (ko) * | 2010-02-12 | 2016-10-17 | 니토 보세키 가부시기가이샤 | Ku86 와 이의 자가항체와의 복합체의 면역 측정 방법, 여기에 사용되는 키트 및 이를 이용한 암판정 방법 |
BR112013004266A8 (pt) | 2010-08-23 | 2018-01-02 | Univ Texas | anticorpos anti-ox40 e métodos de uso dos mesmos. |
HUE033141T2 (en) | 2010-12-02 | 2017-11-28 | Aimm Therapeutics Bv | Instruments and methods for producing high affinity antibodies |
CN102229960B (zh) * | 2011-06-03 | 2013-04-03 | 中国科学院微生物研究所 | 小鼠白血病病毒转化骨髓细胞建立细胞系的方法及其应用 |
KR102542272B1 (ko) | 2011-10-28 | 2023-06-13 | 리제너론 파아마슈티컬스, 인크. | 유전자 변형된 t 세포 수용체 마우스 |
US8962315B2 (en) | 2011-12-22 | 2015-02-24 | Elwha Llc | Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen |
US9175072B2 (en) * | 2011-12-22 | 2015-11-03 | Elwha Llc | Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen |
US10233424B2 (en) | 2011-12-22 | 2019-03-19 | Elwha Llc | Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin |
US10745468B2 (en) | 2011-12-22 | 2020-08-18 | Kota Biotherapeutics, Llc | Compositions and methods for modified B cells expressing reassigned biological agents |
DK2840892T3 (en) * | 2013-02-20 | 2018-07-23 | Regeneron Pharma | Non-human animals with modified heavy chain immunoglobulin sequences |
CN103571796B (zh) * | 2013-11-15 | 2015-04-29 | 中国农业科学院哈尔滨兽医研究所 | 鸡白介素-10单克隆抗体及其制备方法和应用 |
WO2015115892A1 (en) | 2014-01-31 | 2015-08-06 | Aimm Therapeutics B.V. | Means and methods for producing stable antibodies |
US20170058029A1 (en) * | 2014-05-02 | 2017-03-02 | Chiome Bioscience Inc. | Human antibody-producing cell |
US10793642B2 (en) | 2014-12-11 | 2020-10-06 | Inbiomotion S.L. | Binding members for human c-MAF |
ES2959608T3 (es) * | 2015-04-03 | 2024-02-27 | Dana Farber Cancer Inst Inc | Composición y métodos de edición del genoma de células B |
HRP20231039T1 (hr) | 2015-04-06 | 2023-12-22 | Regeneron Pharmaceuticals, Inc. | Imunosni odgovori posredovani humaniziranim t stanicama kod ne-humanih životinja |
EP3320099B1 (en) * | 2015-07-09 | 2023-09-13 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Lentiviral vector expressing membrane-anchored or secreted antibody |
WO2017025871A1 (en) | 2015-08-07 | 2017-02-16 | Glaxosmithkline Intellectual Property Development Limited | Combination therapy comprising anti ctla-4 antibodies |
KR20180042449A (ko) * | 2015-09-15 | 2018-04-25 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | T 세포 수용체(tcr) 결합 항체 및 이의 용도 |
US11377637B2 (en) | 2016-04-15 | 2022-07-05 | Memorial Sloan Kettering Cancer Center | Transgenic T cell and chimeric antigen receptor T cell compositions and related methods |
EP3469069A4 (en) | 2016-06-10 | 2020-01-22 | Kota Biotherapeutics, LLC | COMPOSITIONS AND METHODS COMPRISING A B LYMPHOCYTE CELL LINE EXPRESSING A MEMBRANE IMMUNOGLOBULIN DIFFERENT FROM A SECRETED IMMUNOGLOBULIN AND CYTOLYTIC FUNCTION |
EP3494140A1 (en) | 2016-08-04 | 2019-06-12 | GlaxoSmithKline Intellectual Property Development Ltd | Anti-icos and anti-pd-1 antibody combination therapy |
EP3548068A1 (en) | 2016-12-01 | 2019-10-09 | GlaxoSmithKline Intellectual Property Development Limited | Combination therapy |
BR112019011370A2 (pt) | 2016-12-01 | 2019-10-15 | Glaxosmithkline Ip Dev Ltd | terapia de combinação |
EP3635011A1 (en) | 2017-06-09 | 2020-04-15 | GlaxoSmithKline Intellectual Property Development Limited | Combination therapy with icos agonist and ox40 agonist to treat cancer |
CN110831971A (zh) | 2017-06-09 | 2020-02-21 | 葛兰素史克知识产权开发有限公司 | 用icos激动剂和ox40激动剂治疗癌症的组合疗法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169939A (en) * | 1985-05-21 | 1992-12-08 | Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College | Chimeric antibodies |
US6051225A (en) * | 1988-10-19 | 2000-04-18 | The Dow Chemical Company | Family of high affinity, modified antibodies for cancer treatment |
EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
US5622853A (en) | 1990-05-01 | 1997-04-22 | Becton Dickinson And Company | T lymphocyte precursor |
DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
KR100272077B1 (ko) * | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
US6300129B1 (en) * | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
EP0605522B1 (en) | 1991-09-23 | 1999-06-23 | Medical Research Council | Methods for the production of humanized antibodies |
JPH05184386A (ja) | 1991-12-27 | 1993-07-27 | Sumitomo Chem Co Ltd | 改変抗体及び改変抗体を産生する組み換え体 |
GB9423085D0 (en) | 1994-11-16 | 1995-01-04 | Stringer Bradley M J | Targeted T lymphocytes |
US20040016007A1 (en) * | 2000-05-15 | 2004-01-22 | Sonoko Habu | Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof |
US20050196755A1 (en) | 2000-11-17 | 2005-09-08 | Maurice Zauderer | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
-
2001
- 2001-12-22 US US10/499,631 patent/US7741077B2/en not_active Expired - Fee Related
- 2001-12-22 JP JP2003567945A patent/JP4238138B2/ja not_active Expired - Fee Related
- 2001-12-22 NZ NZ534205A patent/NZ534205A/en unknown
- 2001-12-22 IL IL16211101A patent/IL162111A0/xx unknown
- 2001-12-22 WO PCT/EP2001/015303 patent/WO2003068819A1/en active Application Filing
- 2001-12-22 AU AU2002226390A patent/AU2002226390B2/en not_active Ceased
- 2001-12-22 CN CNB018239560A patent/CN100360565C/zh not_active Expired - Fee Related
- 2001-12-22 CA CA 2471392 patent/CA2471392A1/en not_active Abandoned
-
2004
- 2004-05-20 IL IL162111A patent/IL162111A/en not_active IP Right Cessation
-
2009
- 2009-12-18 US US12/642,754 patent/US20110059056A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN100360565C (zh) | 2008-01-09 |
JP4238138B2 (ja) | 2009-03-11 |
AU2002226390A1 (en) | 2003-09-04 |
US7741077B2 (en) | 2010-06-22 |
JP2005525800A (ja) | 2005-09-02 |
WO2003068819A1 (en) | 2003-08-21 |
CN1633448A (zh) | 2005-06-29 |
NZ534205A (en) | 2006-04-28 |
US20060052585A1 (en) | 2006-03-09 |
AU2002226390B2 (en) | 2007-11-15 |
CA2471392A1 (en) | 2003-08-21 |
US20110059056A1 (en) | 2011-03-10 |
IL162111A (en) | 2009-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162111A0 (en) | Method for the generation of generically modified vertebrate precursor lymphocytes and use thereof for the production of heterologo | |
GB2347938B (en) | Production method for hydrate and device for producing the same | |
AU2002249256A1 (en) | Apparatus and process for the production of hydrogen | |
HK1082393A1 (en) | Toothbrush and method for producing the same | |
EP1428795A4 (en) | SILSESQUIOXANDERIVATE AND METHOD FOR THE PRODUCTION THEREOF | |
EP1535657A4 (en) | MODIFIED SUBSTRATE AND METHOD FOR PRODUCING MODIFIED SUBSTRATE | |
EP1530814A4 (en) | CERAMIC ANODES AND PROCESS FOR PRODUCING THESE ANODES | |
AU2002233670A1 (en) | Process for producing perfluorocarbons and use thereof | |
AU2003281180A1 (en) | Porous semiconductor and process for producing the same | |
AU7265400A (en) | Method for the production of otoplastics and corresponding otoplastic | |
SG91948A1 (en) | Manufacturing method of multilayer substrate and multilayer substrate produced by the manufacturing method | |
AU2003248074A8 (en) | Composite nanoparticle and process for producing the same | |
AU2003261940A8 (en) | Acicular silicon crystal and process for producing the same | |
AU2003291166A8 (en) | Fumed metal oxide particles and process for producing the same | |
GB2386929B (en) | Plain bearing and process for producing the same | |
HUP0401200A3 (en) | Pharmaceutical compositiuons containing terbinafin and process for producing them | |
EP1433833A4 (en) | INDUSTRIAL OIL AND PROCESS FOR PREPARING THE SAME | |
AU2003304246A8 (en) | Method of forming nanostructures on ceramics and the ceramics formed | |
EP1651018A4 (en) | SUBSTRATE AND METHOD FOR PRODUCING THE SAME | |
HK1085304A1 (en) | Superconductor and method of producing the same | |
IL157474A0 (en) | Method for producing a scintillator ceramic and use of the scintillator ceramic | |
EP1484622A4 (en) | PRISM AND CORRESPONDING MANUFACTURING PROCEDURE | |
EP1568655A4 (en) | MICROMACHINE AND PROCESS FOR PRODUCING THE SAME | |
IL143810A0 (en) | Prophylactic article useful for both protection and diagnosis and method for use and production thereof | |
EP1516668A4 (en) | HIGHLY ACTIVE PHOTOCATALYST AND PROCESS FOR PRODUCING THE SAME |